BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30907633)

  • 1. Potential Strategies for Cardiac Diseases: Lineage Reprogramming of Somatic Cells into Induced Cardiomyocytes.
    Wang M; Ling W; Xiong C; Xie D; Chu X; Li Y; Qiu X; Li Y; Xiao X
    Cell Reprogram; 2019 Apr; 21(2):63-77. PubMed ID: 30907633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
    He WJ; Hou Q; Han QW; Han WD; Fu XB
    Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Future of Direct Cardiac Reprogramming: Any
    López-Muneta L; Miranda-Arrubla J; Carvajal-Vergara X
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
    Hodonsky C; Wu K; Mundada L; Si MS
    Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in direct cardiac reprogramming.
    Srivastava D; Yu P
    Curr Opin Genet Dev; 2015 Oct; 34():77-81. PubMed ID: 26454285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
    Panda A; Gurusamy N; Rajasingh S; Carter HK; Thomas EL; Rajasingh J
    Differentiation; 2020; 112():58-66. PubMed ID: 31954271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uses of cardiomyocytes generated from induced pluripotent stem cells.
    Lu TY; Yang L
    Stem Cell Res Ther; 2011 Nov; 2(6):44. PubMed ID: 22099214
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct reprogramming of mouse fibroblasts into cardiac myocytes.
    Inagawa K; Ieda M
    J Cardiovasc Transl Res; 2013 Feb; 6(1):37-45. PubMed ID: 23054660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial reprogramming as a therapeutic approach for heart disease: A state-of-the-art review.
    Talkhabi M
    J Cell Biochem; 2019 Sep; 120(9):14247-14261. PubMed ID: 31081174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosters and barriers for direct cardiac reprogramming.
    Talkhabi M; Zonooz ER; Baharvand H
    Life Sci; 2017 Jun; 178():70-86. PubMed ID: 28427897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
    Budniatzky I; Gepstein L
    Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy for cardiac regeneration: hits and misses.
    Padda J; Sequiera GL; Sareen N; Dhingra S
    Can J Physiol Pharmacol; 2015 Oct; 93(10):835-41. PubMed ID: 26443930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regenerating the human heart: direct reprogramming strategies and their current limitations.
    Ghiroldi A; Piccoli M; Ciconte G; Pappone C; Anastasia L
    Basic Res Cardiol; 2017 Oct; 112(6):68. PubMed ID: 29079873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes.
    Chu AJ; Zhao EJ; Chiao M; Lim CJ
    PLoS One; 2020; 15(4):e0230966. PubMed ID: 32243463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct lineage reprogramming: strategies, mechanisms, and applications.
    Xu J; Du Y; Deng H
    Cell Stem Cell; 2015 Feb; 16(2):119-34. PubMed ID: 25658369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct somatic cell reprogramming: treatment of cardiac diseases.
    Guo C; Patel K; Qian L
    Curr Gene Ther; 2013 Apr; 13(2):133-8. PubMed ID: 23320478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for replacing myocytes with induced pluripotent stem in clinical protocols.
    Hattori F; Fukuda K
    Transplant Rev (Orlando); 2012 Jul; 26(3):223-32. PubMed ID: 22172453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced regeneration--the progress and promise of direct reprogramming for heart repair.
    Addis RC; Epstein JA
    Nat Med; 2013 Jul; 19(7):829-36. PubMed ID: 23836233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.